[Pleuropericardial effusion and systemic inflammatory syndrome secondary to the administration of the mRNA-1273 vaccine for SARS-CoV-2]

Arch Bronconeumol. 2022 Apr;58(4):372-373. doi: 10.1016/j.arbres.2022.01.002. Epub 2022 Jan 6.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Exudates and Transudates
  • Humans
  • SARS-CoV-2*

Substances

  • COVID-19 Vaccines
  • 2019-nCoV Vaccine mRNA-1273